Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

Role of meprin metalloproteinases in cytokine processing and inflammation.

Herzog C, Haun RS, Kaushal GP.

Cytokine. 2019 Feb;114:18-25. doi: 10.1016/j.cyto.2018.11.032. Epub 2018 Dec 20. Review.

PMID:
30580156
2.

Proteolytic processing and inactivation of CCL2/MCP-1 by meprins.

Herzog C, Haun RS, Shah SV, Kaushal GP.

Biochem Biophys Rep. 2016 Aug 21;8:146-150. doi: 10.1016/j.bbrep.2016.08.019. eCollection 2016 Dec.

3.

Epigenetic regulation of KLK7 gene expression in pancreatic and cervical cancer cells.

Raju I, Kaushal GP, Haun RS.

Biol Chem. 2016 Nov 1;397(11):1135-1146. doi: 10.1515/hsz-2015-0307.

PMID:
27279059
4.

Endoplasmic Reticulum Stress-Induced Autophagy Provides Cytoprotection from Chemical Hypoxia and Oxidant Injury and Ameliorates Renal Ischemia-Reperfusion Injury.

Chandrika BB, Yang C, Ou Y, Feng X, Muhoza D, Holmes AF, Theus S, Deshmukh S, Haun RS, Kaushal GP.

PLoS One. 2015 Oct 7;10(10):e0140025. doi: 10.1371/journal.pone.0140025. eCollection 2015.

5.

Novel Use of Proteomic Profiles in a Convex-Hull Ensemble Classifier to Predict Gynecological Cancer Patients' Susceptibility to Gastrointestinal Mucositis as Side Effect of Radiation Therapy.

Kodell RL, Haun RS, Siegel ER, Zhang C, Trammel AB, Hauer-Jensen M, Burnett AF.

J Proteomics Bioinform. 2015 Jul;8(7):149-154. Epub 2015 Jun 25.

6.

Bioorthogonal labeling cell-surface proteins expressed in pancreatic cancer cells to identify potential diagnostic/therapeutic biomarkers.

Haun RS, Quick CM, Siegel ER, Raju I, Mackintosh SG, Tackett AJ.

Cancer Biol Ther. 2015;16(10):1557-65. doi: 10.1080/15384047.2015.1071740. Epub 2015 Jul 15.

7.

Human UDP-Glucuronosyltransferases: Effects of altered expression in breast and pancreatic cancer cell lines.

Dates CR, Fahmi T, Pyrek SJ, Yao-Borengasser A, Borowa-Mazgaj B, Bratton SM, Kadlubar SA, Mackenzie PI, Haun RS, Radominska-Pandya A.

Cancer Biol Ther. 2015;16(5):714-23. doi: 10.1080/15384047.2015.1026480.

8.

Basement membrane protein nidogen-1 is a target of meprin β in cisplatin nephrotoxicity.

Herzog C, Marisiddaiah R, Haun RS, Kaushal GP.

Toxicol Lett. 2015 Jul 16;236(2):110-6. doi: 10.1016/j.toxlet.2015.05.005. Epub 2015 May 6.

9.

CD109 Overexpression in Pancreatic Cancer Identified by Cell-Surface Glycoprotein Capture.

Haun RS, Fan CY, Mackintosh SG, Zhao H, Tackett AJ.

J Proteomics Bioinform. 2014;Suppl 10:S10003.

10.

ADAM10 is the major sheddase responsible for the release of membrane-associated meprin A.

Herzog C, Haun RS, Ludwig A, Shah SV, Kaushal GP.

J Biol Chem. 2014 May 9;289(19):13308-22. doi: 10.1074/jbc.M114.559088. Epub 2014 Mar 24.

11.

Caspase protocols in mice.

Kaushal V, Herzog C, Haun RS, Kaushal GP.

Methods Mol Biol. 2014;1133:141-54. doi: 10.1007/978-1-4939-0357-3_9.

12.

Impact of elevated plasma serotonin on global gene expression of murine megakaryocytes.

Mercado CP, Byrum S, Beggs ML, Ziu E, Singh P, Raj VR, Haun RS, Kilic F.

PLoS One. 2013 Aug 27;8(8):e72580. doi: 10.1371/journal.pone.0072580. eCollection 2013.

13.

Validation of four candidate pancreatic cancer serological biomarkers that improve the performance of CA19.9.

Makawita S, Dimitromanolakis A, Soosaipillai A, Soleas I, Chan A, Gallinger S, Haun RS, Blasutig IM, Diamandis EP.

BMC Cancer. 2013 Sep 3;13:404. doi: 10.1186/1471-2407-13-404.

14.

Meprin A metalloproteinase and its role in acute kidney injury.

Kaushal GP, Haun RS, Herzog C, Shah SV.

Am J Physiol Renal Physiol. 2013 May 1;304(9):F1150-8. doi: 10.1152/ajprenal.00014.2013. Epub 2013 Feb 20. Review.

15.

Expression of kallikrein-related peptidase 7 predicts poor prognosis in patients with unresectable pancreatic ductal adenocarcinoma.

Iakovlev V, Siegel ER, Tsao MS, Haun RS.

Cancer Epidemiol Biomarkers Prev. 2012 Jul;21(7):1135-42. doi: 10.1158/1055-9965.EPI-11-1079. Epub 2012 May 9.

16.

Effects of hyperbaric oxygen on the expression of claudins after cerebral ischemia-reperfusion in rats.

Zhao H, Zhang Q, Xue Y, Chen X, Haun RS.

Exp Brain Res. 2011 Jul;212(1):109-17. doi: 10.1007/s00221-011-2702-3. Epub 2011 May 31.

PMID:
21626096
17.

Proteolytic action of kallikrein-related peptidase 7 produces unique active matrix metalloproteinase-9 lacking the C-terminal hemopexin domains.

Ramani VC, Kaushal GP, Haun RS.

Biochim Biophys Acta. 2011 Aug;1813(8):1525-31. doi: 10.1016/j.bbamcr.2011.05.007. Epub 2011 May 17.

18.

Insulin-like growth factor binding protein-5 influences pancreatic cancer cell growth.

Johnson SK, Haun RS.

World J Gastroenterol. 2009 Jul 21;15(27):3355-66.

19.

Meprin A and meprin alpha generate biologically functional IL-1beta from pro-IL-1beta.

Herzog C, Haun RS, Kaushal V, Mayeux PR, Shah SV, Kaushal GP.

Biochem Biophys Res Commun. 2009 Feb 20;379(4):904-8. doi: 10.1016/j.bbrc.2008.12.161. Epub 2009 Jan 7.

20.

Desmoglein 2 is a substrate of kallikrein 7 in pancreatic cancer.

Ramani VC, Hennings L, Haun RS.

BMC Cancer. 2008 Dec 17;8:373. doi: 10.1186/1471-2407-8-373.

21.
22.

The extracellular matrix protein fibronectin is a substrate for kallikrein 7.

Ramani VC, Haun RS.

Biochem Biophys Res Commun. 2008 May 16;369(4):1169-73. doi: 10.1016/j.bbrc.2008.03.021. Epub 2008 Mar 14.

PMID:
18343220
23.

Transcriptional activation of caspase-6 and -7 genes by cisplatin-induced p53 and its functional significance in cisplatin nephrotoxicity.

Yang C, Kaushal V, Haun RS, Seth R, Shah SV, Kaushal GP.

Cell Death Differ. 2008 Mar;15(3):530-44. Epub 2007 Dec 7.

24.

Kallikrein 7 enhances pancreatic cancer cell invasion by shedding E-cadherin.

Johnson SK, Ramani VC, Hennings L, Haun RS.

Cancer. 2007 May 1;109(9):1811-20.

25.

Differential expression of insulin-like growth factor binding protein-5 in pancreatic adenocarcinomas: identification using DNA microarray.

Johnson SK, Dennis RA, Barone GW, Lamps LW, Haun RS.

Mol Carcinog. 2006 Nov;45(11):814-27.

PMID:
16865675
26.

Generation of biologically active interleukin-1beta by meprin B.

Herzog C, Kaushal GP, Haun RS.

Cytokine. 2005 Sep 7;31(5):394-403.

PMID:
16095909
27.
28.

Diagnosis of pancreatic cancer using serum proteomic profiling.

Bhattacharyya S, Siegel ER, Petersen GM, Chari ST, Suva LJ, Haun RS.

Neoplasia. 2004 Sep-Oct;6(5):674-86.

29.

Sequence, genomic organization, and expression of the human ADP-ribosylation factor 6 (ARF6) gene: a class III ARF.

Lebeda RA, Johnson SK, Stewart MI, Haun RS.

DNA Cell Biol. 2003 Nov;22(11):737-41.

PMID:
14659046
30.

Cloning and characterization of the human ADP-ribosylation factor 4 gene.

Lebeda RA, Haun RS.

Gene. 1999 Sep 3;237(1):209-14.

PMID:
10524252
31.

Transcriptional regulation of the human ADP-ribosylation factor 5 (ARF5) gene.

Lebeda RA, Johnson SK, Haun RS.

Biochim Biophys Acta. 1999 Jun 9;1445(3):314-20.

PMID:
10366714
32.

Steps to building the virtual laboratory.

Haun RS.

Nat Biotechnol. 1997 Jul;15(7):683-4. No abstract available.

PMID:
9219274
33.

Effect of ADP-ribosylation factor amino-terminal deletions on its GTP-dependent stimulation of cholera toxin activity.

Hong JX, Haun RS, Tsai SC, Moss J, Vaughan M.

J Biol Chem. 1994 Apr 1;269(13):9743-5. Erratum in: J Biol Chem 1994 Jun 10;269(23):16519.

34.

Activation of cholera toxin by ADP-ribosylation factors: 20-kDa guanine nucleotide-binding proteins.

Moss J, Haun RS, Tsai SC, Welsh CF, Lee FJ, Price SR, Vaughan M.

Methods Enzymol. 1994;237:44-63. No abstract available.

PMID:
7935017
35.

Effects of brefeldin A and accessory proteins on association of ADP-ribosylation factors 1, 3, and 5 with Golgi.

Tsai SC, Adamik R, Haun RS, Moss J, Vaughan M.

J Biol Chem. 1993 May 25;268(15):10820-5.

36.
37.

Effect of myristoylation on GTP-dependent binding of ADP-ribosylation factor to Golgi.

Haun RS, Tsai SC, Adamik R, Moss J, Vaughan M.

J Biol Chem. 1993 Apr 5;268(10):7064-8.

38.

Differential interaction of ADP-ribosylation factors 1, 3, and 5 with rat brain Golgi membranes.

Tsai SC, Adamik R, Haun RS, Moss J, Vaughan M.

Proc Natl Acad Sci U S A. 1992 Oct 1;89(19):9272-6.

39.

Rapid, reliable ligation-independent cloning of PCR products using modified plasmid vectors.

Haun RS, Serventi IM, Moss J.

Biotechniques. 1992 Oct;13(4):515-8. No abstract available.

PMID:
1362067
40.
41.
43.
44.
45.
47.

Cloning and expression of a protein-tyrosine-phosphatase.

Guan KL, Haun RS, Watson SJ, Geahlen RL, Dixon JE.

Proc Natl Acad Sci U S A. 1990 Feb;87(4):1501-5.

48.

Postnatal development of cholecystokinin-like immunoreactivity and its mRNA level in rat brain regions.

Takeda K, Koshimoto H, Uchiumi F, Haun RS, Dixon JE, Kato T.

J Neurochem. 1989 Sep;53(3):772-8.

PMID:
2760620
49.

Establishment of a cholecystokinin-producing rat medullary thyroid carcinoma cell line.

Haun RS, Beinfeld MC, Roos BA, Dixon JE.

Endocrinology. 1989 Aug;125(2):850-6.

PMID:
2752980
50.

A gene encoding rat cholecystokinin. Isolation, nucleotide sequence, and promoter activity.

Deschenes RJ, Haun RS, Funckes CL, Dixon JE.

J Biol Chem. 1985 Jan 25;260(2):1280-6.

Supplemental Content

Support Center